Aceragen (IDRA) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-26.31M
Loss from disposition of assets
Stock-based compensation	3.5M
Non-employee stock option expense	64K
Depreciation expense
Amortization of investment premiums	360K
Issuance of common stock for services rendered
Accounts receivable
Prepaid expenses and other current assets	-12K
Accounts payable, accrued expenses and other liabilities	121K
Deferred revenue
Net cash used in operating activities
Purchases of available-for-sale securities	-2.95M
Proceeds from maturity of available-for-sale securities	21.3M
Decrease in restricted cash
Purchases of property and equipment	-267K
Net cash provided by (used in) investing activities
Proceeds from exercise of common stock options and employee stock purchases
Payments on capital lease	-5K
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents	-2.52M
Cash and cash equivalents, beginning of period	26.59M
Cash and cash equivalents, end of period	24.06M

Entities mentioned with IDRA

View All Entities